Antibacterial Drugs Market to become Worth US$51,447.6 Mn by 2025

Document technical information

Format docx
Size 47.2 kB
First found Dec 19, 2017

Document content analysis

Category Also themed
Language
English
Type
not defined
Concepts
no text concepts found

Persons

Organizations

Places

Transcript

Antibacterial Drugs Market - Global Industry Analysis, Size, Share,
Growth, Trends and Forecast 2017 - 2025
As competition grows strong in the global antibacterial drugs, the leading
players are finding it more convenience to collaborate with rivals to expand
their product offering as well regional footprint worldwide. In a new study,
Transparency Market Research (TMR) has identified Bayer AG, Pfizer Inc.,
Sanofi, GlaxoSmithKline Plc. (GSK), Merck & Co., Inc., AstraZeneca,
Johnson and Johnson, Bristol Myers Squibb Company, Novartis Ag, and
Allergen Plc as some of the most prominent enterprises operating in the
global antibacterial drugs market. To gain a competitive edge, Pfizer signed
an agreement with AstraZeneca in August 2016. This collaboration was
intended to acquire the commercialization and development rights of latestage small molecule anti-infective business. Besides this, the market
witnessed several other partnerships, collaborations, and acquisitions aimed
at catapulting businesses to the forefront of the global antibacterial drugs
market.
Despite strategies toyed by businesses to gain traction, the subpar pace of
growth is unlikely to change for the global antibacterial drugs market.
According to TMR, the global market is likely to exhibit a CAGR of 1.5%
between 2017 and 2025. Given the growth pace, the market is expected to
reach US$51,447.6 mn by the end of 2025, from US$45,325.0 mn in 2016.
While North America held dominance in the global antibacterial drugs
market in 2016, TMR forecasts sluggish growth for the region through the
forecast period. In terms of drug-class, the B-lactam segment led the market
in 2016.
Browse Full Research Report:
https://www.transparencymarketresearch.com/antibacterial-drugsmarket.html
Antibacterial Drugs Market Witnesses Threat from Looming Patent
Expiries
The rising population of aged people, escalating number of bacterial strains,
which are multidrug resistant, and the rising demand for effective yet
affordable antibacterial drugs will give the market considerable boost over
the forecast period. In addition, TMR predicts the global antibacterial drugs
market to gain significantly from the increasing incidence of infectious
diseases. It is also likely to gain from the rising demand for innovative
molecules. Despite the aforementioned growth prospects, the advent of
genetic drugs for antibacterial activities threatens the overall market. The
looming patent expiries are also identified as key factors restraining the
market. Furthermore, the research and development activities conducted in
the field is insufficient as per many experts. This could pose significant threat
to the overall antibacterial drugs market in the coming years.
Opportunities Prevalent in Emerging Nations to Boost Growth in Near
Future
In the coming years, the market is likely to gain from factors such as the
improved efficacy, fewer side effects, and reduced time of action. In addition,
opportunities prevalent across emerging nations will enable the global
antibacterial drugs market stay afloat during the forecast period. According to
TMR, the market will gain considerable traction in emerging nations such as
India and China.
In the last few years, several synthesis inhibitors have gone off-patent, which
has made TMR predict that several of the drugs under clinical trial could be
approved in the coming years. The likelihood of benefiting from the
commercialization of drug-resistant infections treatment is also rising.
Despite the influx of novel protein synthesis inhibitors, vaccines will remain
the class of drugs contributing the most revenue toward the global
antibacterial drugs market. These factors will enable growth in the global
antibacterial drugs market in the coming years.
Browse Full Press Release:
Press Release
About Us
Transparency Market Research (TMR) is a global market intelligence
company providing business information reports and services. The
company’s exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants use proprietary
data sources and various tools and techniques to gather and analyze
information.
TMR’s data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and information.
With extensive research and analysis capabilities, Transparency Market
Research employs rigorous primary and secondary research techniques to
develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com

Similar documents

×

Report this document